Drug Trial Radar · NCT00386061
Rimonabant in Obesity Over a 2-Year Duration (RIO-Europe)
Last checked: Nov 20, 2026Latest source record: Apr 20, 2009 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Completed
Enrollment
1,507
Actual
Start
Oct 2001
Primary completion
Jun 2004
Study completion Jun 2004
Sponsor
- Lead sponsor
- SanofiSanofi (SNY)
- Sponsor type
- Industry
- First posted
- Oct 11, 2006
Design
- Study type
- Interventional
- Phase
- Phase 3
- Allocation
- Randomized
- Model
- Parallel
- Masking
- Double (participant, investigator)
- Primary purpose
- Treatment
- Who can join
- All sexes, from 18 years
- Healthy volunteers
- No
Summary
As written by the sponsor on the registry.
The primary objective was to assess the effect of SR141716 on weight loss and weight maintenance over a period of one year when prescribed with a hypocaloric diet in obese patients with or without comorbidities. The main secondary objectives were to assess the effect of SR141716 on lipid parameters (HDL-C, TG), glucose tolerance status, the rate of patients with metabolic syndrome, waist circumference, glycemic parameters.
Conditions
- Obesity
Interventions
rimonabant (SR141716)Drug
Primary outcomes
What the sponsor says the trial is designed to measure.
- change in body weight from baseline to 1 year.
Locations
7 sites in 7 countries. Site status is shown where the registry gives one.
Sanofi-Aventis
Bridgewater, New Jersey
Sanofi-Aventis
Brussels, Belgium
Sanofi-Aventis
Helsinki, Finland
Sanofi-Aventis
Paris, France
Sanofi-Aventis
Berlin, Germany
Sanofi-Aventis
Gouda, Netherlands
Sanofi-Aventis
Bromma, Sweden
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.